Actively Recruiting
Use of Al18F-NOTA-FAPI-04 PETCT or PETMRI Imaging for Diagnosis and Treatment Guidance in Malignant Tumors, Cardiovascular, and Immune Diseases
Led by Peking Union Medical College Hospital · Updated on 2026-02-10
600
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the use of Al18F-NOTA-FAPI PET imaging to study its distribution in the body, safety, and accuracy for diagnosing malignant tumors, cardiovascular abnormalities, and autoimmune diseases. The study also aims to understand how this imaging can guide clinical treatment decisions. Additionally, the research will establish normal PETCT or PETMRI images in healthy adults to serve as a reference for future patient assessments. Participants will receive an intravenous injection of the Al18F-NOTA-FAPI tracer, with the dose calculated by weight and administered carefully by qualified staff. Imaging with PETCT or PETMRI will be conducted 45 to 90 minutes after the injection, depending on the tracer availability and equipment. This process helps measure how the tracer spreads and accumulates in various organs and tissues. During the study, safety is monitored from the time of tracer injection up to 24 hours afterward. Diagnostic accuracy for cardiovascular and immune diseases will be assessed over a period of 1 to 1.5 years. Further measurements include evaluating tracer uptake in normal organs and absorbed doses in target organs, continuing for up to six months after the studys completion. Participants may be healthy volunteers or patients meeting specific criteria, and their involvement includes imaging scans and health evaluations.
CONDITIONS
Brief Title
Clinical Application of Al18F-NOTA-FAPI-04 PET/CT or PET/MRI Imaging in Malignant Tumor,Cardiovascular or Immune Disease
Research Team
L
Li Huo, MD
X
Xueqian Yang, MS
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here